61,949 Shares in Danaher Corporation $DHR Acquired by OMERS ADMINISTRATION Corp

Key Points

• OMERS Administration Corp. acquired 61,949 Danaher shares during the second quarter, valued at approximately $11.8 million. Institutional investors and hedge funds collectively own 79.05% of Danaher’s stock.
• Danaher reported quarterly earnings of $1.94 per share, exceeding estimates of $1.85, while revenue rose 5.5% year over year to $6.26 billion.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $228.91, compared with the stock’s reported price of $219.42.

OMERS ADMINISTRATION Corp acquired a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 61,949 shares of the conglomerate's stock, valued at approximately $11,800,000.

Other large investors also recently added to or reduced their stakes in the company. Main Street Group LTD purchased a new stake in shares of Danaher in the first quarter valued at $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher during the second quarter valued at $25,000. JPL Wealth Management LLC acquired a new position in Danaher during the third quarter valued at $25,000. WFA of San Diego LLC acquired a new position in Danaher during the second quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher in the 4th quarter worth about $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Price Performance

Shares of NYSE:DHR opened at $219.42 on Monday. The firm has a market cap of $154.25 billion, a price-to-earnings ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The business has a fifty day simple moving average of $195.80 and a 200 day simple moving average of $192.40.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the previous year, the company posted $0.77 earnings per share. The business's quarterly revenue was up 5.5% compared to the same quarter last year. As a group, sell-side analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

DHR has been the subject of a number of research reports. Weiss Ratings upgraded Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Wednesday, July 15th. HSBC dropped their target price on Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a report on Wednesday, June 3rd. Citigroup assumed coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a "buy" rating and a $230.00 price target for the company. Stifel Nicolaus decreased their price target on shares of Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Finally, TD Cowen lowered their price objective on shares of Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $228.91.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source